Mylan Grabs More FDA Globalization Talent
This article was originally published in The Pink Sheet Daily
Executive Summary
Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.
You may also be interested in...
After Recusal, Schnedar Leaving CDER Compliance Office
Cynthia Schnedar decides to leave several weeks after FDA determined that her husband's promotion could create conflicts of interest.
FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss
While Mylan wants Autor to help push quality improvement efforts around the world, her departure from FDA may affect implementation of similar plans at the agency.
Drug Shortages Give Ben Venue Relief In FDA Consent Decree
The consent decree permits the company to continue to manufacture more than 100 drugs, 20 of which are on FDA’s current drug shortage list. Ben Venue must prove compliance with good manufacturing practice requirements before it can manufacture its other drugs.